An interventional study of Internet based support in Caregivers, Head and Neck Cancer and Feasibility Study, sponsored by Uppsala University. Completed at 4 sites in Sweden. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-02-16.
Sponsored by Uppsala University · Not applicable, Interventional, and Supportive care
Informal caregivers to patients with head and neck cancer report that they are unprepared for caregiving, that they experience a high caregiver burden and a deteriorated health. The aim is to develop an internet based intervention for informal caregivers of individuals with head and neck cancer and evaluate the feasibility and acceptability of the intervention. The internet based intervention (Carer eSupport) will be based on scientific evidence, established theoretical frameworks and focus groups with caregivers and health care professionals. The feasibility and acceptability of Carer eSupport will be evaluated by 30 caregivers who will have access to Carer eSupport during one months. The feasibility and acceptability of Carer eSupport will be evaluated with quantitative and qualitative data.
2,344 studies on the registry are indexed under Head and Neck Neoplasms; 552 are open to participants now.
This study's enrollment of 32 is below the median of 47 across 1,751 interventional studies indexed under Head and Neck Neoplasms.
Browse Head and Neck Neoplasms studies →Uppsala University is the lead sponsor of 381 studies on the registry; 84 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Internet based support for informal caregivers to individuals who are undergoing treatment for head and neck cancer.
Other: Internet based support
Carer eSupport is designed to prepare informal caregivers for caregiving, to decrease caregiver burden and prevent a deteriorated health.
Also known as: Carer eSupport
Inclusion rate
The proportion of caregivers who give informed consent for participation
Time frame: 4 months
Utilization of Carer eSupport
The proportion of included caregivers who take use of Carer eSupport
Time frame: 2 months
Attrition
The proportion of included caregivers who withdraw from the study
Time frame: 3 months
Completion of questionnaires
The proportion of included caregivers who complete questionnaires
Time frame: 3 months
Perceived feasibility
Qualitative data from semi-structured individual interviews exploring perceived feasibility of Carer eSupport.
Time frame: Within 1 months after completion of testing Carer eSupport.
Perceived acceptability
Qualitative data from semi-structured individual interviews exploring perceived acceptability of Carer eSupport.
Time frame: Within 1 months after completion of testing Carer eSupport.
The Preparedness for caregiving scale
A brief 8-item self-report measure assessing preparedness for caregiving, a potential primary outcome in a future randomized controlled trial.
Time frame: Assessed at baseline and at 1 months after access to Carer eSupport
Caregiver´s burden scale
A 22-item self-report measure assessing caregiver burden, a potential primary outcome in a future randomized controlled trial.
Time frame: Assessed at baseline and at 1 months after access to Carer eSupport.
Short Form Health Survey (SF-36), v2.
A 36-item self-report measure assessing self-perceived health, a potential secondary outcome in a future randomized controlled trial.
Time frame: Assessed at baseline and at 1 months after access to Carer eSupport.
The Depression Anxiety Stress Scale-21
A 21-item self-report measure assessing depression, anxiety, and stress, a potential secondary outcome in a future randomized controlled trial.
Time frame: Assessed at baseline and at 1 months after access to Carer eSupport.
The Multidimensional fatigue inventory
A 20-item self-report measure assessing five dimensions of fatigue, a potential secondary outcome in a future randomized controlled trial.
Time frame: Assessed at baseline and at 1 months after access to Carer eSupport.
Plan to share: No — There is no plan to make individual participant data (IPD) available to other researchers, since this is a feasibility study.
This study is completed, as verified in Feb 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Uppsala University